Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Cell-of-Origin (COO) Classification, BCL2 and MYC Expression Associated-Outcome in Younger Patients Treated By RCHOP Front-Line Therapy Versus Intensive Regimen Followed By Autologous Transplant for De Novo Advanced Diffuse Large B Cell Lymphoma (DLBCL) : Results of the French Prospective Multicenter Randomized Trial Goelams -075

Blood (2015) 126 (23): 3920.

https://doi.org/10.1182/blood.V126.23.3920.3920

Published: 2015

Journal Articles

T-Cell Defect in Diffuse Large B-Cell Lymphomas Involves Expansion of Myeloid Derived Suppressor Cells Expressing IL-10, PD-L1, and S100A12

Imane Azzaoui, PhD, Fabrice Uhel, MD, Delphine Rossille, PhD, Céline Pangault, PharmD PhD, Joelle Dulong, Jerome Le Priol, PhD, Thierry Lamy, MDPhD, Roch Houot, MD PhD, Steven Le Gouill, MD PhD, Guillaume Cartron, MD PhD, Pascal Godmer, MD, Krimo Bouabdallah, MD, Noel Milpied, MD PhD, Karin Tarte, PhD, Thierry Fest, MD PhD, Mikael Roussel, MD PhD

Blood (2015) 126 (23): 1478.

https://doi.org/10.1182/blood.V126.23.1478.1478

Published: 2015

Journal Articles

Validation of Elevated Blood Soluble PD-L1 As an Independent Prognostic Marker in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Thierry Fest, MD PhD, James R Cerhan, MD PhD, Maher K Gandhi, PhD FRACP, FRCPath, FRCP, Imane Azzaoui, PhD, Pauline Crooks, BSc, Matthew J Maurer, MS, Noel Milpied, MD PhD, Mark S Hertzberg, MBBS PhDFRACP FRCPA, Thierry Lamy, MD PhD, Stephen M. Ansell, MD PhD, Susan L Slager, PhD, Andrew L. Feldman, MD, Mikael Roussel, MD PhD, Thomas M Habermann, MD, Herve Ghesquieres, MD PhD, Thomas E. Witzig, MD, Brian K Link, MD, Delphine Rossille, PhD

Blood (2014) 124 (21): 2998.

https://doi.org/10.1182/blood.V124.21.2998.2998

Published: 2014

Journal Articles

Blood Soluble PD-L1 Protein In Aggressive Diffuse Large B-Cell Lymphoma Impacts patient’s Overall Survival

Thierry Fest, MD, PhD, Delphine Rossille, PhD, Mélanie Gressier, Pharma.D., MSc, Delphine Maucort-Boulch, MD, PhD, Diane Damotte, MD PhD, Céline Pangault, PharmD, PhD, Steven Le Gouill, MD, PhD, Karin Tarte, PharmD, PhD, Thierry Lamy, MD, PhD, Noel Milpied, MD

Blood (2013) 122 (21): 361.

https://doi.org/10.1182/blood.V122.21.361.361

Published: 2013

Journal Articles

Lymphoma Occurring Over the Age of 90: Clinical Presentation and Outcome

Adrien Trebouet, Tony Marchand, Richard Lemal, Emmanuel Gyan, MD, PhD, Florence Broussais, MD, Yann Guillermin, MD, Hélène Monjanel, Gilles Salles, MD, Steven Le Gouill, Stephanie Boulanger, Sandra Leguyader, Albert Collignon, Delphine Rossille, PhD, Catherine Thieblemont, MD, PhD, Thierry Lamy, MD, PhD, Roch Houot, MD, PhD

Blood (2012) 120 (21): 1582.

https://doi.org/10.1182/blood.V120.21.1582.1582

Published: 2012

Journal Articles

Whole Blood Transcriptional Profiling of DLBCL At Diagnosis: Evidence of Systemic Changes Altering T-Cell Signaling Pathways

Delphine Rossille, PhD, Céline Pangault, PharmD, PhD, Xavier Cahu, MD, Thierry Lamy, MD, PhD, Burgun Anita, MD, PhD, Noel Milpied, MD, Thierry Fest, MD, PhD

Blood (2011) 118 (21): 2435.

https://doi.org/10.1182/blood.V118.21.2435.2435

Published: 2011

Journal Articles

Mesenchymal Stromal Cells Orchestrate Follicular Lymphoma Cell Niche Through the CCL2-Dependent Recruitment and Polarization of Monocytes

Fabien Guilloton, Gersende Caron, Cédric Ménard, Céline Pangault, PharmD, PhD, Patricia Amé-Thomas, Joelle Dulong, John De Vos, Delphine Rossille, PhD, Thierry Lamy, MD, PhD, Thierry Fest, Karin Tarte

Blood (2011) 118 (21): 1566.

https://doi.org/10.1182/blood.V118.21.1566.1566

Published: 2011

NARROW

T-Cell Defect in Diffuse Large B-Cell Lymphomas Involves Expansion of Myeloid Derived Suppressor Cells Expressing IL-10, PD-L1, and S100A12

Validation of Elevated Blood Soluble PD-L1 As an Independent Prognostic Marker in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Blood Soluble PD-L1 Protein In Aggressive Diffuse Large B-Cell Lymphoma Impacts patient’s Overall Survival

Lymphoma Occurring Over the Age of 90: Clinical Presentation and Outcome

Whole Blood Transcriptional Profiling of DLBCL At Diagnosis: Evidence of Systemic Changes Altering T-Cell Signaling Pathways

Mesenchymal Stromal Cells Orchestrate Follicular Lymphoma Cell Niche Through the CCL2-Dependent Recruitment and Polarization of Monocytes

Email alerts

ASH Publications

American Society of Hematology

T-Cell Defect in Diffuse Large B-Cell Lymphomas Involves Expansion of Myeloid Derived Suppressor Cells Expressing IL-10, PD-L1, and S100A12

Validation of Elevated Blood Soluble PD-L1 As an Independent Prognostic Marker in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Blood Soluble PD-L1 Protein In Aggressive Diffuse Large B-Cell Lymphoma Impacts patient’s Overall Survival

Lymphoma Occurring Over the Age of 90: Clinical Presentation and Outcome

Whole Blood Transcriptional Profiling of DLBCL At Diagnosis: Evidence of Systemic Changes Altering T-Cell Signaling Pathways

Mesenchymal Stromal Cells Orchestrate Follicular Lymphoma Cell Niche Through the CCL2-Dependent Recruitment and Polarization of Monocytes

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only